Failed Adoptive Immunotherapy With Tumor-Specific T Cells

Cancer Research - United States
doi 10.1158/0008-5472.can-04-1860
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Application of Genetically Engineered Tumor-Specific Th1 Cells to Adoptive Tumor Immunotherapy

Annals of Cancer Research and Therapy
Cancer ResearchOncologyPharmacology
2004English

Adoptive Cancer Immunotherapy With Human Vγ2vδ2 T Cells

English

Antigen-Specific Culture of Memory-Like CD8 T Cells for Adoptive Immunotherapy

Cancer immunology research
Cancer ResearchImmunology
2014English

Adoptive Immunotherapy of Cancer Using CD4+ T Cells

Current Opinion in Immunology
AllergyImmunology
2009English

ErbB2/HER2-specific NK Cells for Adoptive Cancer Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Enhancing Adoptive Cancer Immunotherapy With Vγ2Vδ2 T Cells Through Pulse Zoledronate Stimulation

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

Enrichment and Expansion With Nanoscale Artificial Antigen Presenting Cells for T Cell Adoptive Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Adoptive T-Cell Therapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors

International Journal of Hematology
Hematology
2013English

Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes Against Metastatic Liver Tumors.

Acta Hepatologica Japonica
Hepatology
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy